Werkgroep Cardiologische centra Nederland

PROMINENT (Completed)

Pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in diabetic patients
Medicine
pemafibrate
Population
Diabetes mellitus
Phase
III
Starting year
2016
More information
Clinicaltrials.gov